Form 4: NEOGEN Chief Legal Officer's Stock Transactions

NEOGEN's Chief Legal Officer, Amy M. Rocklin, reported the vesting and settlement of 294 Restricted Stock Units into common stock, followed by a sale of 115 shares for tax purposes.

Summary

• Amy M. Rocklin, Chief Legal Officer of NEOGEN CORP, reported transactions involving the company's common stock.
• On October 13, 2025, 294 Restricted Stock Units (RSUs) vested and were settled for an equal number of common stock shares.
• Concurrently, 294 shares of common stock were acquired at a price of $6.04 per share.
• Following the acquisition, 115 shares of common stock were disposed of at $6.04 per share, likely to cover tax obligations related to the RSU vesting.
• After these transactions, Amy M. Rocklin beneficially owns 49,851 shares of NEOGEN common stock.

Sentiment

Score: 6

Explanation: The filing reports a routine insider transaction involving the vesting of Restricted Stock Units and a subsequent sale of shares to cover tax obligations, which is a standard compensation event for executives. This is a neutral to slightly positive event as it reflects ongoing executive compensation.

Positives

• The vesting of 294 Restricted Stock Units represents a planned compensation event for the Chief Legal Officer, indicating continued alignment of executive incentives with shareholder interests.

Negatives

• A disposition of 115 shares of common stock occurred, which, while likely for tax withholding, results in a slight reduction in the reporting person's direct equity ownership.

Future Outlook

NA

Industry Context

This filing is a routine insider transaction report and does not provide information directly related to broader industry trends or competitive landscape. It reflects standard executive compensation practices within publicly traded companies.

Stakeholder Impact

• Shareholders: The transaction is a routine compensation event and does not materially alter the company's financial position or strategic direction. It reflects the ongoing alignment of executive incentives.
• Employees: No direct impact on general employees is indicated by this filing.

Key Dates

Recommendation

This Form 4 filing details a routine, pre-scheduled insider transaction related to executive compensation (RSU vesting and tax-related share sale). It does not provide new material information about the company's operational performance, financial health, or strategic direction that would warrant a change in investment recommendation. Investors should consider broader company fundamentals and market conditions.

Keywords

NEOGEN, NEOG, Form 4, Insider Trading, Restricted Stock Units, RSU Vesting, Common Stock, Executive Compensation, Amy M. Rocklin